nasdaq:srpt
|
https://www.indeed.com/cmp/sarepta-therapeutics
|
Aug 29th, 2022 12:00AM
|
Open
|
Sarepta Therapeutics
|
|
Pharmaceutical & Biotechnology
|
Sarepta Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the discovery and development of unique RNA-based therapeutics for the treatment of rare and infectious diseases. The company is primarily focused on rapidly advancing the development of its potentially disease modifying duchenne muscular dystrophy drug candidates, including its lead product candidate, eteplirsen. Sarepta Therapeutics was founded on July 22, 1980 and is headquartered in Cambridge, MA.
|
RRv1_100M_500M
|
215 First Street Cambridge, MA 02142 Main phone: 617.274.4000
|
|
|
|
4.20
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15.00
|
15.00
|
3.50
|
4.00
|
3.40
|
3.60
|
4.10
|
6.00
|
About a week
|
6.00
|
DIFFICULT
|
5.00
|
FAVORABLE
|
|
|
|
Aug 29th, 2022 12:37PM
|
Aug 29th, 2022 12:37PM
|
Sarepta Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:srpt
|
https://www.indeed.com/cmp/sarepta-therapeutics
|
Aug 28th, 2022 12:00AM
|
Open
|
Sarepta Therapeutics
|
|
Pharmaceutical & Biotechnology
|
Sarepta Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the discovery and development of unique RNA-based therapeutics for the treatment of rare and infectious diseases. The company is primarily focused on rapidly advancing the development of its potentially disease modifying duchenne muscular dystrophy drug candidates, including its lead product candidate, eteplirsen. Sarepta Therapeutics was founded on July 22, 1980 and is headquartered in Cambridge, MA.
|
RRv1_100M_500M
|
215 First Street Cambridge, MA 02142 Main phone: 617.274.4000
|
|
|
|
4.20
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15.00
|
15.00
|
3.50
|
4.00
|
3.40
|
3.60
|
4.10
|
6.00
|
About a week
|
6.00
|
DIFFICULT
|
5.00
|
FAVORABLE
|
|
|
|
Aug 28th, 2022 05:38AM
|
Aug 28th, 2022 05:38AM
|
Sarepta Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:srpt
|
https://www.indeed.com/cmp/sarepta-therapeutics
|
Aug 27th, 2022 12:00AM
|
Open
|
Sarepta Therapeutics
|
|
Pharmaceutical & Biotechnology
|
Sarepta Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the discovery and development of unique RNA-based therapeutics for the treatment of rare and infectious diseases. The company is primarily focused on rapidly advancing the development of its potentially disease modifying duchenne muscular dystrophy drug candidates, including its lead product candidate, eteplirsen. Sarepta Therapeutics was founded on July 22, 1980 and is headquartered in Cambridge, MA.
|
RRv1_100M_500M
|
215 First Street Cambridge, MA 02142 Main phone: 617.274.4000
|
|
|
|
4.20
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15.00
|
15.00
|
3.50
|
4.00
|
3.40
|
3.60
|
4.10
|
6.00
|
About a week
|
6.00
|
DIFFICULT
|
5.00
|
FAVORABLE
|
|
|
|
Aug 27th, 2022 04:56AM
|
Aug 27th, 2022 04:56AM
|
Sarepta Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:srpt
|
https://www.indeed.com/cmp/sarepta-therapeutics
|
Aug 25th, 2022 12:00AM
|
Open
|
Sarepta Therapeutics
|
|
Pharmaceutical & Biotechnology
|
Sarepta Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the discovery and development of unique RNA-based therapeutics for the treatment of rare and infectious diseases. The company is primarily focused on rapidly advancing the development of its potentially disease modifying duchenne muscular dystrophy drug candidates, including its lead product candidate, eteplirsen. Sarepta Therapeutics was founded on July 22, 1980 and is headquartered in Cambridge, MA.
|
RRv1_100M_500M
|
215 First Street Cambridge, MA 02142 Main phone: 617.274.4000
|
|
|
|
4.20
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15.00
|
15.00
|
3.50
|
4.00
|
3.40
|
3.60
|
4.10
|
6.00
|
About a week
|
6.00
|
DIFFICULT
|
5.00
|
FAVORABLE
|
|
|
|
Aug 25th, 2022 09:36AM
|
Aug 25th, 2022 09:36AM
|
Sarepta Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:srpt
|
https://www.indeed.com/cmp/sarepta-therapeutics
|
Aug 23rd, 2022 12:00AM
|
Open
|
Sarepta Therapeutics
|
|
Pharmaceutical & Biotechnology
|
Sarepta Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the discovery and development of unique RNA-based therapeutics for the treatment of rare and infectious diseases. The company is primarily focused on rapidly advancing the development of its potentially disease modifying duchenne muscular dystrophy drug candidates, including its lead product candidate, eteplirsen. Sarepta Therapeutics was founded on July 22, 1980 and is headquartered in Cambridge, MA.
|
RRv1_100M_500M
|
215 First Street Cambridge, MA 02142 Main phone: 617.274.4000
|
|
|
|
4.20
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15.00
|
15.00
|
3.50
|
4.00
|
3.40
|
3.60
|
4.10
|
6.00
|
About a week
|
6.00
|
DIFFICULT
|
5.00
|
FAVORABLE
|
|
|
|
Aug 23rd, 2022 11:28AM
|
Aug 23rd, 2022 11:28AM
|
Sarepta Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:srpt
|
https://www.indeed.com/cmp/sarepta-therapeutics
|
Aug 21st, 2022 12:00AM
|
Open
|
Sarepta Therapeutics
|
|
Pharmaceutical & Biotechnology
|
Sarepta Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the discovery and development of unique RNA-based therapeutics for the treatment of rare and infectious diseases. The company is primarily focused on rapidly advancing the development of its potentially disease modifying duchenne muscular dystrophy drug candidates, including its lead product candidate, eteplirsen. Sarepta Therapeutics was founded on July 22, 1980 and is headquartered in Cambridge, MA.
|
RRv1_100M_500M
|
215 First Street Cambridge, MA 02142 Main phone: 617.274.4000
|
|
|
|
4.20
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15.00
|
15.00
|
3.50
|
4.00
|
3.40
|
3.60
|
4.10
|
6.00
|
About a week
|
6.00
|
DIFFICULT
|
5.00
|
FAVORABLE
|
|
|
|
Aug 21st, 2022 01:13PM
|
Aug 21st, 2022 01:13PM
|
Sarepta Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:srpt
|
https://www.indeed.com/cmp/sarepta-therapeutics
|
Aug 20th, 2022 12:00AM
|
Open
|
Sarepta Therapeutics
|
|
Pharmaceutical & Biotechnology
|
Sarepta Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the discovery and development of unique RNA-based therapeutics for the treatment of rare and infectious diseases. The company is primarily focused on rapidly advancing the development of its potentially disease modifying duchenne muscular dystrophy drug candidates, including its lead product candidate, eteplirsen. Sarepta Therapeutics was founded on July 22, 1980 and is headquartered in Cambridge, MA.
|
RRv1_100M_500M
|
215 First Street Cambridge, MA 02142 Main phone: 617.274.4000
|
|
|
|
4.20
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15.00
|
15.00
|
3.50
|
4.00
|
3.40
|
3.60
|
4.10
|
6.00
|
About a week
|
6.00
|
DIFFICULT
|
5.00
|
FAVORABLE
|
|
|
|
Aug 20th, 2022 02:51PM
|
Aug 20th, 2022 02:51PM
|
Sarepta Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:srpt
|
https://www.indeed.com/cmp/sarepta-therapeutics
|
Aug 19th, 2022 12:00AM
|
Open
|
Sarepta Therapeutics
|
|
Pharmaceutical & Biotechnology
|
Sarepta Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the discovery and development of unique RNA-based therapeutics for the treatment of rare and infectious diseases. The company is primarily focused on rapidly advancing the development of its potentially disease modifying duchenne muscular dystrophy drug candidates, including its lead product candidate, eteplirsen. Sarepta Therapeutics was founded on July 22, 1980 and is headquartered in Cambridge, MA.
|
RRv1_100M_500M
|
215 First Street Cambridge, MA 02142 Main phone: 617.274.4000
|
|
|
|
4.20
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15.00
|
15.00
|
3.50
|
4.00
|
3.40
|
3.60
|
4.10
|
6.00
|
About a week
|
6.00
|
DIFFICULT
|
5.00
|
FAVORABLE
|
|
|
|
Aug 19th, 2022 01:12PM
|
Aug 19th, 2022 01:12PM
|
Sarepta Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:srpt
|
https://www.indeed.com/cmp/sarepta-therapeutics
|
Aug 18th, 2022 12:00AM
|
Open
|
Sarepta Therapeutics
|
|
Pharmaceutical & Biotechnology
|
Sarepta Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the discovery and development of unique RNA-based therapeutics for the treatment of rare and infectious diseases. The company is primarily focused on rapidly advancing the development of its potentially disease modifying duchenne muscular dystrophy drug candidates, including its lead product candidate, eteplirsen. Sarepta Therapeutics was founded on July 22, 1980 and is headquartered in Cambridge, MA.
|
RRv1_100M_500M
|
215 First Street Cambridge, MA 02142 Main phone: 617.274.4000
|
|
|
|
4.20
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15.00
|
15.00
|
3.50
|
4.00
|
3.40
|
3.60
|
4.10
|
6.00
|
About a week
|
6.00
|
DIFFICULT
|
5.00
|
FAVORABLE
|
|
|
|
Aug 18th, 2022 04:56AM
|
Aug 18th, 2022 04:56AM
|
Sarepta Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:srpt
|
https://www.indeed.com/cmp/sarepta-therapeutics
|
Aug 17th, 2022 12:00AM
|
Open
|
Sarepta Therapeutics
|
|
Pharmaceutical & Biotechnology
|
Sarepta Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the discovery and development of unique RNA-based therapeutics for the treatment of rare and infectious diseases. The company is primarily focused on rapidly advancing the development of its potentially disease modifying duchenne muscular dystrophy drug candidates, including its lead product candidate, eteplirsen. Sarepta Therapeutics was founded on July 22, 1980 and is headquartered in Cambridge, MA.
|
RRv1_100M_500M
|
215 First Street Cambridge, MA 02142 Main phone: 617.274.4000
|
|
|
|
4.20
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15.00
|
15.00
|
3.50
|
4.00
|
3.40
|
3.60
|
4.10
|
6.00
|
About a week
|
6.00
|
DIFFICULT
|
5.00
|
FAVORABLE
|
|
|
|
Aug 17th, 2022 10:35AM
|
Aug 17th, 2022 10:35AM
|
Sarepta Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|